Laboratoires Théa

Laboratoires Théa is the leading independent European pharmaceutical group specialized in the research, development, and commercialization of eye-care products. Founded by Henri Chibret, a member of a five-generation ophthalmological dynasty, the company has pioneered many of the most significant advances in the field, most notably the development of the ABAK® system, the first multi-dose preservative-free eye drop bottle. This technology has allowed the company to become a global leader in preservative-free ophthalmic treatments. Headquartered in Clermont-Ferrand, France, Théa operates a global network with over 35 subsidiaries and offices across Europe, North Africa, North and South America, and the Middle East. The company maintains a comprehensive portfolio covering major therapeutic classes including glaucoma, dry eye, allergy, infection, and inflammation, as well as surgical and diagnostic products. In recent years, Théa has aggressively expanded its pipeline through strategic acquisitions and partnerships, particularly in the fields of rare genetic retinal diseases and innovative drug delivery systems.